SCHEMBL26020727

SCHEMBL26020727

c1ccc2cc3c(cc2c1)oc1cc(N(c2ccc(-c4cccc5ccccc45)cc2)c2ccc(-c4cc5ccccc5c5ccccc45)cc2)ccc13

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MCL1 Q07820 1/20 0.34
▸ ACMSD Q8TDX5 1/20 0.34
▸ ENPP3 O14638 1/20 0.34
▸ ENPP1 P22413 1/20 0.34
▸ CA12 O43570 2/20 0.33
▸ CA1 P00915 2/20 0.33
▸ CA2 P00918 2/20 0.33
▸ CA9 Q16790 2/20 0.33
▸ CHRNB4 P30926 1/20 0.33
▸ CHRNA3 P32297 1/20 0.33
▸ CHRNA7 P36544 1/20 0.33
▸ PPARG P37231 4/20 0.33
▸ PPARA Q07869 4/20 0.33
▸ HDAC8 Q9BY41 1/20 0.33
▸ HDAC6 Q9UBN7 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ CASP1 P29466 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26020527 0.95 ALDH1A1 (0.34) MCL1ACMSDENPP3ENPP1CA12
SCHEMBL26020553 0.94 MCL1 (0.32) MCL1ACMSDENPP3ENPP1CA12
SCHEMBL26489490 0.94 MCL1 (0.37) MCL1ACMSDENPP3ENPP1CA12
SCHEMBL23822257 0.93 AHR (0.36) MCL1ACMSDENPP3ENPP1CA12
SCHEMBL26061541 0.92 MCL1 (0.34) MCL1ACMSDENPP3ENPP1PPARG
SCHEMBL24361319 0.92 GPR84 (0.36) CA12CA9ALDH1A1HPGDL3MBTL1
SCHEMBL26490579 0.92 MCL1 (0.39) MCL1ACMSDENPP3ENPP1CA12
SCHEMBL24361596 0.91 GPR84 (0.37) MCL1CA12CA9ALDH1A1HPGD
SCHEMBL24361672 0.91 GPR84 (0.37) MCL1CA12CA9ALDH1A1HPGD
SCHEMBL26489472 0.91 MCL1 (0.35) MCL1ACMSDENPP3ENPP1CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230242498-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME LG CHEM, LTD. (KR) 2023-08-03 — — US disclosed
US-20230242498-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME LG CHEM, LTD. (KR) 2023-08-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230242498-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME CRY1, CRY2, NR1D1 MCL1 1794/4885ACMSD 2326/4885ENPP3 4201/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback